AU2002230579A1 - Calcilytic compounds - Google Patents
Calcilytic compoundsInfo
- Publication number
- AU2002230579A1 AU2002230579A1 AU2002230579A AU3057902A AU2002230579A1 AU 2002230579 A1 AU2002230579 A1 AU 2002230579A1 AU 2002230579 A AU2002230579 A AU 2002230579A AU 3057902 A AU3057902 A AU 3057902A AU 2002230579 A1 AU2002230579 A1 AU 2002230579A1
- Authority
- AU
- Australia
- Prior art keywords
- calcilytic compounds
- compounds
- calcilytic
- methods
- novel calcilytic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000001126 calcilytic effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24300700P | 2000-10-25 | 2000-10-25 | |
US60/243,007 | 2000-10-25 | ||
PCT/US2001/046233 WO2002034204A2 (en) | 2000-10-25 | 2001-10-25 | Calcilytic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002230579A1 true AU2002230579A1 (en) | 2002-05-06 |
Family
ID=22916980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002230579A Abandoned AU2002230579A1 (en) | 2000-10-25 | 2001-10-25 | Calcilytic compounds |
Country Status (8)
Country | Link |
---|---|
US (1) | US20040014723A1 (de) |
EP (1) | EP1383511B1 (de) |
JP (1) | JP2004514659A (de) |
AT (1) | ATE343390T1 (de) |
AU (1) | AU2002230579A1 (de) |
DE (1) | DE60124148T2 (de) |
ES (1) | ES2273909T3 (de) |
WO (1) | WO2002034204A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR042132A1 (es) | 2002-11-26 | 2005-06-08 | Smithkline Beecham Corp | Compuesto de 2- hidroxi -3-(2- aril - 1, 1 - dimetiletilamino) propoxifenilo, composicion farmaceutica que lo comprende y uso del mismo para prepararla |
NZ541188A (en) | 2003-04-23 | 2008-01-31 | Japan Tobacco Inc | calcium receptor antagonists |
JPWO2004106280A1 (ja) | 2003-05-28 | 2006-07-20 | 日本たばこ産業株式会社 | CaSRアンタゴニスト |
JP5025795B2 (ja) * | 2008-06-05 | 2012-09-12 | 旭化成ファーマ株式会社 | スルホンアミド化合物及びその用途 |
WO2010113860A1 (ja) * | 2009-03-31 | 2010-10-07 | 第一三共株式会社 | ビフェニル-環状アミン化合物 |
DE102011083595A1 (de) | 2011-09-28 | 2013-03-28 | Bayer Pharma AG | Inhibition der Wirkung von Interleukin 1 beta zur Behandlung der Endometriose |
GB201217330D0 (en) | 2012-09-28 | 2012-11-14 | Univ Cardiff | Therapeutic for treating inflammatory lung disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5789397A (en) * | 1991-01-08 | 1998-08-04 | Bone Care International, Inc. | Methods for preparation and use of 1A,24(S)-dihydroxy vitamin D2 |
DE4141928A1 (de) * | 1991-12-19 | 1993-06-24 | Boehringer Mannheim Gmbh | Neue phosphonobernsteinsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
IL126458A (en) * | 1996-04-09 | 2004-06-20 | Nps Pharma Inc | Calcium receptor inhibiting calcilytic compounds |
UY24949A1 (es) * | 1997-04-08 | 2001-04-30 | Smithkline Beecham Corp | Compuestos calcilíticos |
AR014975A1 (es) * | 1998-04-08 | 2001-04-11 | Nps Pharma Inc | Compuestos calciliticos, una composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de un medicamento |
PE20000415A1 (es) * | 1998-04-08 | 2000-05-21 | Smithkline Beecham Corp | Compuestos calciliticos |
PE20001456A1 (es) * | 1999-02-02 | 2001-01-28 | Smithkline Beecham Corp | Compuestos calcioliticos |
AR030684A1 (es) * | 2000-01-24 | 2003-09-03 | Smithkline Beecham Corp | Compuestos calciliticos, uso de dichos compuestos en la manufactura de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos |
-
2001
- 2001-10-25 AT AT01988571T patent/ATE343390T1/de not_active IP Right Cessation
- 2001-10-25 DE DE60124148T patent/DE60124148T2/de not_active Expired - Lifetime
- 2001-10-25 US US10/415,118 patent/US20040014723A1/en not_active Abandoned
- 2001-10-25 ES ES01988571T patent/ES2273909T3/es not_active Expired - Lifetime
- 2001-10-25 AU AU2002230579A patent/AU2002230579A1/en not_active Abandoned
- 2001-10-25 JP JP2002537258A patent/JP2004514659A/ja not_active Withdrawn
- 2001-10-25 WO PCT/US2001/046233 patent/WO2002034204A2/en active IP Right Grant
- 2001-10-25 EP EP01988571A patent/EP1383511B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2002034204A8 (en) | 2003-12-24 |
EP1383511A4 (de) | 2005-05-18 |
WO2002034204A2 (en) | 2002-05-02 |
DE60124148D1 (de) | 2006-12-07 |
EP1383511B1 (de) | 2006-10-25 |
WO2002034204A3 (en) | 2003-11-06 |
EP1383511A2 (de) | 2004-01-28 |
ES2273909T3 (es) | 2007-05-16 |
ATE343390T1 (de) | 2006-11-15 |
DE60124148T2 (de) | 2007-09-06 |
US20040014723A1 (en) | 2004-01-22 |
JP2004514659A (ja) | 2004-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL147803A0 (en) | 28-epirapalogs | |
AU2001239725A1 (en) | Antibacterial agents | |
AU2003299585A1 (en) | Water-soluble products and methods of making and using the same | |
JO2410B1 (en) | 6. Replaced pyrido-pyrimidines | |
WO2003035617A3 (en) | Derivatives of uk-2a | |
AU2002367580A1 (en) | Tissue-engineered organs | |
MY133969A (en) | Indoloquinazolinones | |
AU2003290592A1 (en) | Antitumor benzoylsulfonamides | |
MXPA01010403A (es) | Agentes quimiotacticos e inhibidores derivados de osteopontina y usos de los mismos. | |
HK1045990A1 (en) | Novel derivatives and analogues of galanthamin. | |
AP2001002220A0 (en) | Calcilytic compounds. | |
AP2002002547A0 (en) | Calcilytic compounds. | |
AU2002230579A1 (en) | Calcilytic compounds | |
MY133881A (en) | "calcilytic compounds" | |
MXPA02011558A (es) | Inhibidores de mmp-2/mp-9 novedosos. | |
AU2002358179A1 (en) | New rennets | |
WO2002038106A3 (en) | Calcilytic compounds | |
TW200510276A (en) | Calcilytic compounds | |
AU2002356615A1 (en) | Novel utilization of cyclopentabenzofurans | |
AU2001278773A1 (en) | Novel pla1 | |
AUPQ599500A0 (en) | Novel peptides, modulatory agents therefor and methods of using them | |
AU2001267699A1 (en) | Testing of leather | |
AU2001258330A1 (en) | New uses of imidazolylmethyl-pyridines | |
AU2001233715A1 (en) | Dermo- and gastro-specific sphingolipid activator | |
AU2001287673A1 (en) | Novel trioxepan compounds |